resveratrol has been researched along with Airway Hyper-Responsiveness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardi, A; de Oliveira, MTP; de Sá Coutinho, D; Martins, MA; Pohlmann, AR; Silva, PMR; Stanisçuaski Guterres, S; Tenório de Souza, É | 1 |
| Deng, Y; Fu, Z; Li, S; Li, W; Liu, E; Long, X; Ren, L; Xie, J; Xie, X; Xu, F; Zang, N | 1 |
2 other study(ies) available for resveratrol and Airway Hyper-Responsiveness
| Article | Year |
|---|---|
Orally delivered resveratrol-loaded lipid-core nanocapsules ameliorate LPS-induced acute lung injury via the ERK and PI3K/Akt pathways.
Topics: Acute Lung Injury; Administration, Oral; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cytokines; Extracellular Signal-Regulated MAP Kinases; Inflammation Mediators; Lipopolysaccharides; Lung; Male; Mice, Inbred Strains; Nanocapsules; Neutrophils; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Respiratory Hypersensitivity; Resveratrol; Signal Transduction | 2019 |
Resveratrol suppresses persistent airway inflammation and hyperresponsivess might partially via nerve growth factor in respiratory syncytial virus-infected mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain-Derived Neurotrophic Factor; Bronchoalveolar Lavage Fluid; Female; Interferon-gamma; Lung; Mice; Mice, Inbred BALB C; Nerve Growth Factor; Pneumonia; Respiratory Function Tests; Respiratory Hypersensitivity; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Resveratrol; RNA, Viral; Stilbenes | 2015 |